Tag: research
Do you really need to give an NSAID after cataract surgery?...
A study of almost 90,000 patients undergoing cataract surgery examined the effects of perioperative NSAIDs and steroids vs just steroids.
Their question....do NSAIDs really make a difference...
Do you really need to give an NSAID after cataract surgery?...
A study of almost 90,000 patients undergoing cataract surgery examined the effects of perioperative NSAIDs and steroids vs just steroids.
Their question....do NSAIDs really make a difference...
PSA to patients: Pink eye is not an emergency.
A study published in Ophthalmology last week reviewed over 370,000 eye related emergency room visits from over a 14 year period.
The results? Â Brace yourself.
One in four...
A nasal spray could be a treatment for optic neuritis.
Optic neuritis is the most common presenting sign of MS and up to 60% of patients develop permanent visual deficits.
What is the drug?
It's called...
Myopia cell found!
Researchers at Northwestern in Chicago may have found a retinal ganglion cell responsible for myopia and it might be linked with the amount time spent indoors.
What...
Looking ahead…
A gel drop may replace the bandage contact lens.
Ocular Bandage Gel is a clear viscous hydrogel eye drop (0.75% concentration of CMHA-S hydrogel), capable of...
What your patient says may not be what is recorded in...
In a study published in JAMA Ophthalmology, researchers compared symptoms that 162 patients checked off on paper-based questionnaires with the information entered in patients’ electronic charts...
If you perform or advocate for ODs to perform laser trabeculoplasty...
A recent study shows optometrists performing LTP have a "189% greater hazard as compared to ophthalmologists".
After reviewing Medicare claims from glaucoma patients in Oklahoma from 2008-2013, over 1000...
AMD and risk of progression.
A new study asks, if a patient has unilateral AMD (early or late), what is the chance they will develop bilateral AMD in the next 5...
Lucentis gets another FDA approval.
The FDA announced the approval of Lucentis to treat myopic choroidal neovascularization (mCNV) making this the fifth FDA approved indication for Lucentis. Â This approval...